High-Throughput Screening (HTS) is a powerful method used in drug discovery to quickly assess the biological or biochemical activity of a large number of compounds. This technique involves the automation of experiments to evaluate thousands to millions of samples for their potential as drug candidates.
The global High-Throughput Screening (HTS) for Drug Discovery market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淗igh-Throughput Screening (HTS) for Drug Discovery Industry Forecast鈥� looks at past sales and reviews total world High-Throughput Screening (HTS) for Drug Discovery sales in 2023, providing a comprehensive analysis by region and market sector of projected High-Throughput Screening (HTS) for Drug Discovery sales for 2024 through 2030. With High-Throughput Screening (HTS) for Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High-Throughput Screening (HTS) for Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global High-Throughput Screening (HTS) for Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on High-Throughput Screening (HTS) for Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global High-Throughput Screening (HTS) for Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High-Throughput Screening (HTS) for Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High-Throughput Screening (HTS) for Drug Discovery.
United States market for High-Throughput Screening (HTS) for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for High-Throughput Screening (HTS) for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for High-Throughput Screening (HTS) for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key High-Throughput Screening (HTS) for Drug Discovery players cover Thermo Fisher Scientific, Agilent, Merck, Danaher, Revvity, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of High-Throughput Screening (HTS) for Drug Discovery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Consumables
Instruments
Segmentation by Application:
Pharmaceuticals
Biological Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Agilent
Merck
Danaher
Revvity
Tecan Group
Bio-Rad Laboratories
Corning Incorporated
Mettler-Toledo International
Lonza
Waters Corporation
Sartorius AG
Eppendorf
Porvair
Greiner AG
Charles River Laboratories
Eurofins Scientific
Hamilton
Aurora Biomed
Gilson
Brand GmbH+Co
BMG Labtech
DIANA Biotechnologies
Creative Biolabs
HighRes Biosolutions
Biomat
AXXAM S.p.A.
Sygnature Discovery
Crown Bioscience
Key Questions Addressed in this Report
What is the 10-year outlook for the global High-Throughput Screening (HTS) for Drug Discovery market?
What factors are driving High-Throughput Screening (HTS) for Drug Discovery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do High-Throughput Screening (HTS) for Drug Discovery market opportunities vary by end market size?
How does High-Throughput Screening (HTS) for Drug Discovery break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global High-Throughput Screening (HTS) for Drug Discovery Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for High-Throughput Screening (HTS) for Drug Discovery by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for High-Throughput Screening (HTS) for Drug Discovery by Country/Region, 2019, 2023 & 2030
2.2 High-Throughput Screening (HTS) for Drug Discovery Segment by Type
2.2.1 Consumables
2.2.2 Instruments
2.3 High-Throughput Screening (HTS) for Drug Discovery Sales by Type
2.3.1 Global High-Throughput Screening (HTS) for Drug Discovery Sales Market Share by Type (2019-2024)
2.3.2 Global High-Throughput Screening (HTS) for Drug Discovery Revenue and Market Share by Type (2019-2024)
2.3.3 Global High-Throughput Screening (HTS) for Drug Discovery Sale Price by Type (2019-2024)
2.4 High-Throughput Screening (HTS) for Drug Discovery Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Biological Laboratories
2.4.3 Others
2.5 High-Throughput Screening (HTS) for Drug Discovery Sales by Application
2.5.1 Global High-Throughput Screening (HTS) for Drug Discovery Sale Market Share by Application (2019-2024)
2.5.2 Global High-Throughput Screening (HTS) for Drug Discovery Revenue and Market Share by Application (2019-2024)
2.5.3 Global High-Throughput Screening (HTS) for Drug Discovery Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global High-Throughput Screening (HTS) for Drug Discovery Breakdown Data by Company
3.1.1 Global High-Throughput Screening (HTS) for Drug Discovery Annual Sales by Company (2019-2024)
3.1.2 Global High-Throughput Screening (HTS) for Drug Discovery Sales Market Share by Company (2019-2024)
3.2 Global High-Throughput Screening (HTS) for Drug Discovery Annual Revenue by Company (2019-2024)
3.2.1 Global High-Throughput Screening (HTS) for Drug Discovery Revenue by Company (2019-2024)
3.2.2 Global High-Throughput Screening (HTS) for Drug Discovery Revenue Market Share by Company (2019-2024)
3.3 Global High-Throughput Screening (HTS) for Drug Discovery Sale Price by Company
3.4 Key Manufacturers High-Throughput Screening (HTS) for Drug Discovery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers High-Throughput Screening (HTS) for Drug Discovery Product Location Distribution
3.4.2 Players High-Throughput Screening (HTS) for Drug Discovery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for High-Throughput Screening (HTS) for Drug Discovery by Geographic Region
4.1 World Historic High-Throughput Screening (HTS) for Drug Discovery Market Size by Geographic Region (2019-2024)
4.1.1 Global High-Throughput Screening (HTS) for Drug Discovery Annual Sales by Geographic Region (2019-2024)
4.1.2 Global High-Throughput Screening (HTS) for Drug Discovery Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic High-Throughput Screening (HTS) for Drug Discovery Market Size by Country/Region (2019-2024)
4.2.1 Global High-Throughput Screening (HTS) for Drug Discovery Annual Sales by Country/Region (2019-2024)
4.2.2 Global High-Throughput Screening (HTS) for Drug Discovery Annual Revenue by Country/Region (2019-2024)
4.3 Americas High-Throughput Screening (HTS) for Drug Discovery Sales Growth
4.4 APAC High-Throughput Screening (HTS) for Drug Discovery Sales Growth
4.5 Europe High-Throughput Screening (HTS) for Drug Discovery Sales Growth
4.6 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Sales Growth
5 Americas
5.1 Americas High-Throughput Screening (HTS) for Drug Discovery Sales by Country
5.1.1 Americas High-Throughput Screening (HTS) for Drug Discovery Sales by Country (2019-2024)
5.1.2 Americas High-Throughput Screening (HTS) for Drug Discovery Revenue by Country (2019-2024)
5.2 Americas High-Throughput Screening (HTS) for Drug Discovery Sales by Type (2019-2024)
5.3 Americas High-Throughput Screening (HTS) for Drug Discovery Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC High-Throughput Screening (HTS) for Drug Discovery Sales by Region
6.1.1 APAC High-Throughput Screening (HTS) for Drug Discovery Sales by Region (2019-2024)
6.1.2 APAC High-Throughput Screening (HTS) for Drug Discovery Revenue by Region (2019-2024)
6.2 APAC High-Throughput Screening (HTS) for Drug Discovery Sales by Type (2019-2024)
6.3 APAC High-Throughput Screening (HTS) for Drug Discovery Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe High-Throughput Screening (HTS) for Drug Discovery by Country
7.1.1 Europe High-Throughput Screening (HTS) for Drug Discovery Sales by Country (2019-2024)
7.1.2 Europe High-Throughput Screening (HTS) for Drug Discovery Revenue by Country (2019-2024)
7.2 Europe High-Throughput Screening (HTS) for Drug Discovery Sales by Type (2019-2024)
7.3 Europe High-Throughput Screening (HTS) for Drug Discovery Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery by Country
8.1.1 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Sales by Country (2019-2024)
8.1.2 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Revenue by Country (2019-2024)
8.2 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Sales by Type (2019-2024)
8.3 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of High-Throughput Screening (HTS) for Drug Discovery
10.3 Manufacturing Process Analysis of High-Throughput Screening (HTS) for Drug Discovery
10.4 Industry Chain Structure of High-Throughput Screening (HTS) for Drug Discovery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 High-Throughput Screening (HTS) for Drug Discovery Distributors
11.3 High-Throughput Screening (HTS) for Drug Discovery Customer
12 World Forecast Review for High-Throughput Screening (HTS) for Drug Discovery by Geographic Region
12.1 Global High-Throughput Screening (HTS) for Drug Discovery Market Size Forecast by Region
12.1.1 Global High-Throughput Screening (HTS) for Drug Discovery Forecast by Region (2025-2030)
12.1.2 Global High-Throughput Screening (HTS) for Drug Discovery Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global High-Throughput Screening (HTS) for Drug Discovery Forecast by Type (2025-2030)
12.7 Global High-Throughput Screening (HTS) for Drug Discovery Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Agilent
13.2.1 Agilent Company Information
13.2.2 Agilent High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.2.3 Agilent High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Agilent Main Business Overview
13.2.5 Agilent Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.3.3 Merck High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Danaher
13.4.1 Danaher Company Information
13.4.2 Danaher High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.4.3 Danaher High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Danaher Main Business Overview
13.4.5 Danaher Latest Developments
13.5 Revvity
13.5.1 Revvity Company Information
13.5.2 Revvity High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.5.3 Revvity High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Revvity Main Business Overview
13.5.5 Revvity Latest Developments
13.6 Tecan Group
13.6.1 Tecan Group Company Information
13.6.2 Tecan Group High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.6.3 Tecan Group High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Tecan Group Main Business Overview
13.6.5 Tecan Group Latest Developments
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Information
13.7.2 Bio-Rad Laboratories High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.7.3 Bio-Rad Laboratories High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bio-Rad Laboratories Main Business Overview
13.7.5 Bio-Rad Laboratories Latest Developments
13.8 Corning Incorporated
13.8.1 Corning Incorporated Company Information
13.8.2 Corning Incorporated High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.8.3 Corning Incorporated High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Corning Incorporated Main Business Overview
13.8.5 Corning Incorporated Latest Developments
13.9 Mettler-Toledo International
13.9.1 Mettler-Toledo International Company Information
13.9.2 Mettler-Toledo International High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.9.3 Mettler-Toledo International High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Mettler-Toledo International Main Business Overview
13.9.5 Mettler-Toledo International Latest Developments
13.10 Lonza
13.10.1 Lonza Company Information
13.10.2 Lonza High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.10.3 Lonza High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Lonza Main Business Overview
13.10.5 Lonza Latest Developments
13.11 Waters Corporation
13.11.1 Waters Corporation Company Information
13.11.2 Waters Corporation High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.11.3 Waters Corporation High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Waters Corporation Main Business Overview
13.11.5 Waters Corporation Latest Developments
13.12 Sartorius AG
13.12.1 Sartorius AG Company Information
13.12.2 Sartorius AG High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.12.3 Sartorius AG High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Sartorius AG Main Business Overview
13.12.5 Sartorius AG Latest Developments
13.13 Eppendorf
13.13.1 Eppendorf Company Information
13.13.2 Eppendorf High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.13.3 Eppendorf High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Eppendorf Main Business Overview
13.13.5 Eppendorf Latest Developments
13.14 Porvair
13.14.1 Porvair Company Information
13.14.2 Porvair High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.14.3 Porvair High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Porvair Main Business Overview
13.14.5 Porvair Latest Developments
13.15 Greiner AG
13.15.1 Greiner AG Company Information
13.15.2 Greiner AG High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.15.3 Greiner AG High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Greiner AG Main Business Overview
13.15.5 Greiner AG Latest Developments
13.16 Charles River Laboratories
13.16.1 Charles River Laboratories Company Information
13.16.2 Charles River Laboratories High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.16.3 Charles River Laboratories High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Charles River Laboratories Main Business Overview
13.16.5 Charles River Laboratories Latest Developments
13.17 Eurofins Scientific
13.17.1 Eurofins Scientific Company Information
13.17.2 Eurofins Scientific High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.17.3 Eurofins Scientific High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Eurofins Scientific Main Business Overview
13.17.5 Eurofins Scientific Latest Developments
13.18 Hamilton
13.18.1 Hamilton Company Information
13.18.2 Hamilton High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.18.3 Hamilton High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Hamilton Main Business Overview
13.18.5 Hamilton Latest Developments
13.19 Aurora Biomed
13.19.1 Aurora Biomed Company Information
13.19.2 Aurora Biomed High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.19.3 Aurora Biomed High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Aurora Biomed Main Business Overview
13.19.5 Aurora Biomed Latest Developments
13.20 Gilson
13.20.1 Gilson Company Information
13.20.2 Gilson High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.20.3 Gilson High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Gilson Main Business Overview
13.20.5 Gilson Latest Developments
13.21 Brand GmbH+Co
13.21.1 Brand GmbH+Co Company Information
13.21.2 Brand GmbH+Co High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.21.3 Brand GmbH+Co High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Brand GmbH+Co Main Business Overview
13.21.5 Brand GmbH+Co Latest Developments
13.22 BMG Labtech
13.22.1 BMG Labtech Company Information
13.22.2 BMG Labtech High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.22.3 BMG Labtech High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 BMG Labtech Main Business Overview
13.22.5 BMG Labtech Latest Developments
13.23 DIANA Biotechnologies
13.23.1 DIANA Biotechnologies Company Information
13.23.2 DIANA Biotechnologies High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.23.3 DIANA Biotechnologies High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 DIANA Biotechnologies Main Business Overview
13.23.5 DIANA Biotechnologies Latest Developments
13.24 Creative Biolabs
13.24.1 Creative Biolabs Company Information
13.24.2 Creative Biolabs High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.24.3 Creative Biolabs High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Creative Biolabs Main Business Overview
13.24.5 Creative Biolabs Latest Developments
13.25 HighRes Biosolutions
13.25.1 HighRes Biosolutions Company Information
13.25.2 HighRes Biosolutions High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.25.3 HighRes Biosolutions High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 HighRes Biosolutions Main Business Overview
13.25.5 HighRes Biosolutions Latest Developments
13.26 Biomat
13.26.1 Biomat Company Information
13.26.2 Biomat High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.26.3 Biomat High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Biomat Main Business Overview
13.26.5 Biomat Latest Developments
13.27 AXXAM S.p.A.
13.27.1 AXXAM S.p.A. Company Information
13.27.2 AXXAM S.p.A. High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.27.3 AXXAM S.p.A. High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.27.4 AXXAM S.p.A. Main Business Overview
13.27.5 AXXAM S.p.A. Latest Developments
13.28 Sygnature Discovery
13.28.1 Sygnature Discovery Company Information
13.28.2 Sygnature Discovery High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.28.3 Sygnature Discovery High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.28.4 Sygnature Discovery Main Business Overview
13.28.5 Sygnature Discovery Latest Developments
13.29 Crown Bioscience
13.29.1 Crown Bioscience Company Information
13.29.2 Crown Bioscience High-Throughput Screening (HTS) for Drug Discovery Product Portfolios and Specifications
13.29.3 Crown Bioscience High-Throughput Screening (HTS) for Drug Discovery Sales, Revenue, Price and Gross Margin (2019-2024)
13.29.4 Crown Bioscience Main Business Overview
13.29.5 Crown Bioscience Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
